Core Insights - TruBridge, Inc. has announced an expanded exclusive partnership with RevSpring to enhance its healthcare technology solutions for rural and community hospitals [1][2] Partnership Details - The collaboration integrates RevSpring's patient engagement and payment optimization solutions into the TruBridge connected platform, aiming to improve financial performance and access to care in rural America [2][4] - This partnership is designed to empower rural healthcare organizations with sophisticated tools similar to those used by larger health systems, enhancing patient relationships and financial performance [4] New Capabilities - The expanded partnership introduces an intelligence suite that addresses individual affordability, helping rural providers increase collections, reduce bad debt, and elevate patient satisfaction [3] - TruBridge clients have already seen up to a 37% increase in cash receipts and patient satisfaction scores exceeding 95% [3] Technology and Solutions - RevSpring's Engage IQ™ solution is highlighted as the only connected patient engagement suite that coordinates patient interactions from pre-care to post-care to payment [6] - The intelligent payment suite utilizes predictive analytics to tailor communication channels and payment options to individual patient preferences, enhancing engagement and operational efficiency [7][8]

CareCloud (NasdaqGM:CCLD) Update Summary Company Overview - CareCloud is focused on modernizing patient phone access in healthcare through AI-driven solutions, specifically the Stratus AI Desk Agent [1][2] Industry Context - The traditional front desk model in healthcare is becoming unsustainable due to staffing shortages, burnout, and increasing patient demands [4][5] - Phone calls remain the primary access channel for patients, despite the rise of digital tools [3][4] Core Challenges Identified - Staffing issues lead to long hold times, missed calls, and frustrated patients, resulting in revenue leakage [4][5] - Traditional solutions like hiring more staff or implementing IVR systems are inadequate for handling unpredictable spikes in call volume [4][5] Stratus AI Desk Agent Solution - Stratus AI Desk Agent is an AI-powered voice agent designed to handle patient calls through natural conversations, available 24/7 [5][6] - It supports unlimited simultaneous calls, detects intent and sentiment in real-time, and integrates with CareCloud's practice management and EHR systems [6][7] - The AI agent can manage scheduling, prescription refills, and general inquiries without increasing staff workload [9][10] Performance Metrics - Stratus AI boasts a 97% call resolution success rate, with nearly 80% of inbound calls handled autonomously [11][12] - The solution leads to fewer no-shows and better schedule utilization, contributing to stronger revenue flow [11][12] Financial Implications - A typical practice handling 2,000 inbound calls per month could save approximately $7,200 monthly or over $86,000 annually by using Stratus AI, with a projected ROI exceeding 200% [13][14] - The pricing model is based on successful calls handled by AI, making it flexible and risk-free with a 30-day trial [12][13] Security and Compliance - Stratus AI is designed to be HIPAA compliant, ensuring patient data protection through end-to-end encryption and secure EHR synchronization [11] Customer Feedback - Positive testimonials highlight that Stratus AI allows staff to focus on complex patient needs while maintaining high service standards [12] Implementation and Customization - The implementation process typically takes 2 to 4 weeks, with customization options available to fit specific practice needs [16][40] - The AI can handle multiple languages and is designed to integrate seamlessly with existing workflows [16][39] Future Developments - Plans to introduce an outbound calling agent to proactively reach out to patients for follow-ups and reminders [32] Conclusion - Stratus AI Desk Agent represents a significant advancement in healthcare operations, providing immediate patient access, scalable operations, and improved staff satisfaction without adding operational burdens [23][41]

Core Insights - Codoxo, a leader in AI and generative AI-powered healthcare payment integrity solutions, has successfully raised $35 million in Series C funding [1] - The funding round was led by CVS Health Ventures, with participation from new investor Echo Health Ventures and continued support from existing investors including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures, and QED Investors [1] Company Overview - Codoxo specializes in healthcare payment integrity solutions that leverage AI and generative AI technologies [1] - The recent funding milestone enhances Codoxo's financial position and supports its growth strategy in the healthcare sector [1]

AI assisted Health Cube open to patients in Guardia Perticara (Basilicata), Italy VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to announce that it has completed installation of its H3 Health Cube in Italy. Sold through UniDoc's in-country partner, UniCheck SRL, the Health Cube at the Territorial eHealth Centre in Guardia Perticara (Basilicata), Italy, reflects continued execution in the Basilicata region. ...

Core Viewpoint - OptimizeRx Corp. has announced four new partner agreements that significantly enhance its point-of-care (POC) network, strengthen its competitive position, and expand its National Provider Identifier (NPI) reach [1][2]. Partnership Agreements - The new agreements include partnerships with an eRx platform and a health systems access partner, which together increase OptimizeRx's unique NPI reach by 37% [3][9]. - The eRx platform was previously part of a competitive network, while the health systems access partner allows OptimizeRx to engage healthcare professionals (HCPs) at critical points in patient care [3][9]. Strategic Footprint Expansion - These partnerships reinforce OptimizeRx's leadership in the POC marketing landscape and secure exclusive access to premium inventory, enhancing visibility into future channel revenue [4][10]. - Renewals with top-performing EHR and eRx platforms further solidify these relationships, based on historical strong utilization and high returns on investment (ROIs) for life sciences brands [4][10]. Growth Positioning - The CEO of OptimizeRx emphasized that deepening relationships with high-value partners and gaining access to large-scale platforms positions the company for sustained, profitable growth [5]. - The company aims to enhance its clients' ability to reach a larger audience of relevant providers, driving brand awareness and conversion [5][10]. Technology and Innovation - OptimizeRx utilizes innovative, AI-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood® Targeting (MNT) to facilitate timely and relevant engagement between life sciences brands and healthcare providers [6]. - The company's commitment to privacy-safe, patient-centric technology aims to deliver impactful interactions that improve patient outcomes [7].

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company utilizes its software platform, Clover Assistant, to aggregate patient data across the healthcare ecosystem, supporting clinical decision-making and improving health outcomes through early identification and management of chronic diseases [2] - Clover Health offers PPO and HMO Medicare Advantage plans in multiple states, emphasizing its flagship wide-network, high-choice PPO plans [2] Technology and Impact - The technology platform has demonstrated positive impacts on various health metrics, including Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and outcomes in Underserved Populations [2] - The company aims to enhance patient outcomes and reduce healthcare costs on a nationwide scale through its subsidiary, Counterpart Health, which extends the benefits of its data-driven technology to a broader audience [2] Upcoming Events - The CEO of Clover Health, Andrew Toy, is scheduled to present at the J.P. Morgan 2026 Healthcare Conference on January 15, 2026, at 11:15 a.m. Eastern Time, with a live webcast available on the company's investor relations website [1]

Core Insights - Hims & Hers Health, Inc. (HIMS) demonstrates a growth trajectory where scale, profitability, and reinvestment are developing simultaneously, with Q3 2025 revenues approaching $600 million and positive net income despite significant investments in technology and marketing [1][7] Group 1: Financial Performance - HIMS reported a net income in Q3 2025 while continuing to invest heavily in technology, marketing, and platform expansion [7] - The Zacks Consensus Estimate for HIMS' 2025 earnings per share indicates a 77.8% improvement from 2024 [8] - HIMS shares have increased by 16.5% over the past year, outperforming the industry decline of 3.7% [6] Group 2: Strategic Developments - HIMS is expanding its platform from episodic care to personalized, longitudinal health management, with new offerings in lab testing, weight-loss, hormone health, and women's health specialties [2] - The acquisition of YourBio Health and the appointment of an AI-focused chief technology officer emphasize HIMS' commitment to data, personalization, and user experience as growth drivers [2] - Geographic expansion into Canada, the U.K., and Europe reflects confidence in the business model, with management accepting near-term margin volatility for long-term growth [3] Group 3: Valuation Metrics - HIMS has a forward 12-month price-to-sales (P/S) ratio of 3X, which is lower than the industry average of 4.7X but higher than its three-year median of 2.6X [10] - HIMS currently holds a Zacks Rank 3 (Hold) [12]

BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence (AI) for the early detection of eye-related health issues, is pleased to announce the appointment of Dr. Ismail Ben Ayed, as Chief Artificial Intelligence (AI) Scientist. Mr. Ben Ayed is an expert in medical image analysis algorithms, machine learning and computer vision. Mr. Ben Ayed will guide the Company’ ...

港仔机器人主动健管团队利用自研算法重构了中医古籍、现代权威教材及百万级医学问答对，构建了高质量训练数据集，采用指令微调技术，成功将异构的 中医理论体系深度内化为模型参数，赋予了HKR_TCM_HW_v1 强大的中医综合能力。 HKR_TCM_HW_v1 不仅实现了中医大模型技术的新突破，更为中医主动健康管理提供了全新视角。港仔机器人主动健管团队以HKR_TCM_HW_v1为核 心，打造了中医养生超级智能体，作为港仔机器人 AI 主动健康中心全流程服务的核心引擎，为用户提供中医健康分析、中医健康调控方案生成等一站式服 务。 该榜单的支持单位还包括上海中医药大学、中国中医科学院。MedBench平台全方位考察了大模型中医综合能力，紧扣中医基础、经典理解、临床诊疗、中 药方剂、针灸推拿五大核心维度，以多维度试题及真实临床病案场景设计考题，力求精准评估模型的中医专业素养与实战应用水平。 AI 主动健康中心，由香港本土首家具身智能机器人企业港仔机器人与国内预防医学领军企业美年健康（002044）联合研发，是新一代智能健康管理解决方 案的标杆之作。 智通财经APP了解到，近日，由上海人工智能实验室（人工智能领域国家级研发 ...

WALTHAM, Mass.--(BUSINESS WIRE)-- #ai--With 2026 fast approaching, the healthcare sector is poised for the next stage of gains in AI adoption. Predictions point to increasingly strategic implementation of productivity enablers as well as advancements in clinical decision making technology that connect clinicians with better answers to care for their patients. To highlight what obstacles and opportunities in healthcare technology lie ahead in 2026, leading experts from Wolters Kluwer Health share thei. ...